「我们使用了标准Cochrane方法」——2016至2023年Cochrane综述摘要按PRISMA-A报告规范的观察性研究
该回顾性观察研究从MEDLINE随机抽取2016至2023年Cochrane综述摘要520篇,纳入489篇有效性综述,由两名评价者独立提取PRISMA-A依从性、标准方法使用及GRADE报告情况。结果显示PRISMA-A完整报告条目均分维持在6.9至7.2分(满分12分),摘要中位长度从686词增至866词,标准方法报告率从27.4%升至53.2%,GRADE报告率从30.7%升至74.2%。
要点
- PRISMA-A依从性历年未变,摘要更多报告结果而非方法。
- 摘要中位长度从686词增至866词,主要增加在结果部分。
- 标准方法报告率从27.4%升至53.2%,GRADE从30.7%升至74.2%。
核心结论
- Cochrane综述摘要的PRISMA-A依从性多年来保持不变,报告结果信息多于方法信息。
- 这与PRISMA-A推荐明确说明所用方法相冲突,该推荐自2023年8月起构成Cochrane手册摘要报告的基础。
- 因此,Cochrane作者和编辑应密切监测是否报告了所用标准方法。
研究设计与样本
- 回顾性观察性研究,基于2016至2023年MEDLINE(通过PubMed)索引的合格Cochrane综述。
- 采用分层随机抽样共抽取520篇摘要,最终纳入489篇关于有效性的Cochrane综述。
- 由两名评价者独立提取PRISMA-A依从性、标准方法使用报告及GRADE报告情况,数据按发表年份和标准方法报告进行描述性分层分析。
主要发现
- 2016至2023年间,PRISMA-A完全报告条目的均分范围为6.9至7.2分(满分12分)。
- 摘要中位长度从686词增加至866词,尤其在结果部分。
- 报告使用标准方法的比例从27.4%上升至53.2%,报告GRADE的比例从30.7%上升至74.2%。
- 报告使用标准方法的摘要更常符合PRISMA-A中关于结果的个别条目,而较少符合关于方法的条目,总体PRISMA-A依从性无差异。
关键数值与推荐
- PRISMA-A完全报告条目均分:2016至2023年间为6.9至7.2分(满分12分)。
- 摘要中位长度:从686词增至866词。
- 报告使用标准方法的比例:从27.4%升至53.2%。
- 报告GRADE的比例:从30.7%升至74.2%。
临床怎么用
- Cochrane作者和编辑应密切监测是否报告了所用标准方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate reporting of abstracts of Cochrane reviews (CRs) according to PRISMA-A over the last years and trends in reporting the use of standard Cochrane methods and GRADE. STUDY DESIGN AND SETTING: This was a retrospective, observational study based on eligible CRs indexed in MEDLINE (via PubMed) from 2016 to 2023. Stratified random sample with a total of 520 abstracts was drawn and 489 CRs on effectiveness were included. PRISMA-A adherence, reporting use of standard methods, and GRADE were extracted by two reviewers independently. Data were analyzed descriptively and stratified by publication year and reporting of standard methods. RESULTS: Mean score of fully reported PRISMA-A items ranged from 6.9 to 7.2 out of 12 between 2016 and 2023, whereas abstract length increased from a median of 686 to 866 words, particularly in the results section. Over the years, reporting that standard methods were used increased from 27.4% to 53.2% and for GRADE from 30.7% to 74.2%. Abstracts reporting the use of standard methods more often adhere to individual PRISMA-A items on results and less often on methods with no differences in overall PRISMA-A adherence. CONCLUSION: PRISMA-A adherence in CR abstracts has remained unchanged over the years, with reporting more information on results than methods. This conflicts with PRISMA-A, which recommends specifying the methods used, forms the basis for reporting abstracts in the Cochrane Handbook since August 2023. Therefore, Cochrane authors and editors should closely monitor the reporting whether standard methods were used.
引用
- Wandscher K, Helbach J, Pieper D, et al. "We used standard Cochrane methods" - observational study on reporting according to PRISMA-A in Cochrane review abstracts between 2016 and 2023. J Clin Epidemiol. 2025. PMID: 39924127. doi:10.1016/j.jclinepi.2025.111713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。